Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software Platform

Desktop Genetics Ltd (“DTG” or “the Company”), a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding from Illumina, Inc.

Please to read the entire article.

You must be logged in to post a comment Login